These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33036937)

  • 1. Antibody Therapy Goes to Insects: Monoclonal Antibodies Can Block Plasmodium Transmission to Mosquitoes.
    Coelho CH; Jore MM; Canepa GE; Barillas-Mury C; Bousema T; Duffy PE
    Trends Parasitol; 2020 Nov; 36(11):880-883. PubMed ID: 33036937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Novel approach toward infectious diseases--combating malaria by using genetically engineered mosquitoes].
    Yoshida S; Shimada Y; Watanabe H
    Nihon Rinsho; 2007 Sep; 65(9):1715-26. PubMed ID: 17877001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease.
    Crompton PD; Moebius J; Portugal S; Waisberg M; Hart G; Garver LS; Miller LH; Barillas-Mury C; Pierce SK
    Annu Rev Immunol; 2014; 32():157-87. PubMed ID: 24655294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biology of Malaria Transmission.
    Meibalan E; Marti M
    Cold Spring Harb Perspect Med; 2017 Mar; 7(3):. PubMed ID: 27836912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strain-transcending neutralization of malaria parasite by antibodies against Plasmodium falciparum enolase.
    Dutta S; Tewari A; Balaji C; Verma R; Moitra A; Yadav M; Agrawal P; Sahal D; Jarori GK
    Malar J; 2018 Aug; 17(1):304. PubMed ID: 30126436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Plasmodium falciparum transmission reducing immunity among primary school children in a malaria moderate transmission region in Zimbabwe.
    Paul NH; Vengesai A; Mduluza T; Chipeta J; Midzi N; Bansal GP; Kumar N
    Acta Trop; 2016 Nov; 163():103-8. PubMed ID: 27491342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to plant-produced Plasmodium falciparum sexual stage protein Pfs25 exhibit transmission blocking activity.
    Farrance CE; Chichester JA; Musiychuk K; Shamloul M; Rhee A; Manceva SD; Jones RM; Mamedov T; Sharma S; Mett V; Streatfield SJ; Roeffen W; van de Vegte-Bolmer M; Sauerwein RW; Wu Y; Muratova O; Miller L; Duffy P; Sinden R; Yusibov V
    Hum Vaccin; 2011; 7 Suppl():191-8. PubMed ID: 21266847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current studies related to the development of transmission-blocking malaria vaccines: a review.
    Meuwissen JH
    Trans R Soc Trop Med Hyg; 1989; 83 Suppl():57-60. PubMed ID: 2576163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting gametocyte biology in malaria parasites.
    Ngotho P; Soares AB; Hentzschel F; Achcar F; Bertuccini L; Marti M
    FEMS Microbiol Rev; 2019 Jul; 43(4):401-414. PubMed ID: 31220244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum.
    Rener J; Graves PM; Carter R; Williams JL; Burkot TR
    J Exp Med; 1983 Sep; 158(3):976-81. PubMed ID: 6350527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biology of sexual development of Plasmodium: the design and implementation of transmission-blocking strategies.
    Sinden RE; Carter R; Drakeley C; Leroy D
    Malar J; 2012 Mar; 11():70. PubMed ID: 22424474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commit, hide and escape: the story of Plasmodium gametocytes.
    Beri D; Balan B; Tatu U
    Parasitology; 2018 Nov; 145(13):1772-1782. PubMed ID: 30008275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium Oocysts: Overlooked Targets of Mosquito Immunity.
    Smith RC; Barillas-Mury C
    Trends Parasitol; 2016 Dec; 32(12):979-990. PubMed ID: 27639778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies.
    Quakyi IA; Carter R; Rener J; Kumar N; Good MF; Miller LH
    J Immunol; 1987 Dec; 139(12):4213-7. PubMed ID: 2447164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies & recent development of transmission-blocking vaccines against
    Chaturvedi N; Bharti PK; Tiwari A; Singh N
    Indian J Med Res; 2016 Jun; 143(6):696-711. PubMed ID: 27748294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naturally acquired immunity to sexual stage P. falciparum parasites.
    Stone WJ; Dantzler KW; Nilsson SK; Drakeley CJ; Marti M; Bousema T; Rijpma SR
    Parasitology; 2016 Feb; 143(2):187-98. PubMed ID: 26743529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An inter-laboratory comparison of standard membrane-feeding assays for evaluation of malaria transmission-blocking vaccines.
    Miura K; Stone WJ; Koolen KM; Deng B; Zhou L; van Gemert GJ; Locke E; Morin M; Bousema T; Sauerwein RW; Long CA; Dechering KJ
    Malar J; 2016 Sep; 15(1):463. PubMed ID: 27612458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.
    Miura K; Keister DB; Muratova OV; Sattabongkot J; Long CA; Saul A
    Malar J; 2007 Aug; 6():107. PubMed ID: 17686163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy model for mosquito stage transmission blocking vaccines for malaria.
    Saul A
    Parasitology; 2008 Nov; 135(13):1497-506. PubMed ID: 18257944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current developments in malaria transmission-blocking vaccines.
    Stowers A; Carter R
    Expert Opin Biol Ther; 2001 Jul; 1(4):619-28. PubMed ID: 11727498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.